 |
|
|
|
|
|
|
|
|
|
|
|
1 to 16 of 16 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Rajendran L. on PAPER: Steele JW. et al., 2012, With the twin papers (one on AD and the other on α-synucleinopathy) in Mol. Psychiatry, Sam... 15 Aug 2012.
|
|
|
 |
|
|
Paolicelli R, Rajendran L. on PAPER: Deane R. et al., 2012, Alzheimer’s disease is a multifactorial and multigenetic disease. However, to procure a systems... 25 Apr 2012.
|
|
|
|
|
|
Bali J, Rajendran L. on PAPER: Ill-Raga G. et al., 2011, Poly (I:C) Effects on Alzheimer’s Disease—BACE1 and Hence Aβ Dependent?
Causes for... 6 Sep 2011.
|
|
|
|
|
|
Rajendran L. on PAPER: Sannerud R. et al., 2011, This elegant cell biology study adds another important piece to the puzzle of how endocytosis... 17 Aug 2011.
|
|
|
|
|
|
Rajendran L. on PAPER: Jo J. et al., 2011, We recently witnessed the discovery of many Aβ receptors, but the exact signaling pathway... 5 Apr 2011.
|
|
|
|
|
|
Rajendran L. on PAPER: Emmanouilidou E. et al., 2010, Cytosolic Amyloids: Being Out Is In
In the last few months, the neurodegeneration... 3 Jun 2010.
|
|
|
|
|
|
Rajendran L. on PAPER: Wakabayashi T. et al., 2009, Another beautiful work on the biochemistry of γ-secretase complex from the group of Bart de... 23 Oct 2009.
|
|
|
|
|
|
Rajendran L. on NEWS: Technology Brief: Advances in Nanoscopy Deliver Cellular Close-Ups, Recommendation Only. 9 Sep 2009.
|
|
|
|
|
|
Rajendran L. on PAPER: Zhang C. et al., 2009, Recommendation Only. 7 Sep 2009.
|
|
|
|
|
|
Rajendran L. on PAPER: Desplats P. et al., 2009, It was a pleasure to read this work from the Masliah/Lee duo on the cell-to-cell transmission of... 20 Aug 2009.
|
|
|
|
|
|
Rajendran L. on NEWS: Drifting Toward AD—Epigenetic Changes Linked to Disease, Recommendation Only. 23 Jul 2008.
|
|
|
|
|
|
Rajendran L. on NEWS: BACE Inhibitors Hitch Ride into Endosomes via Membrane Anchor, I have to thank Alzforum's new reporter, Esther Landhuis, for the coverage on our recent study.... 5 Jun 2008.
|
|
|
|
|
|
Rajendran L. on PAPER: Hébert SS. et al., 2008, An excellent piece of work by Sebastien, Bart, and colleagues. This study underscores the role... 5 Jun 2008.
|
|
|
|
|
|
Rajendran L. on PAPER: Böhm C. et al., 2006, Recommendation Only. 17 Mar 2006.
|
|
|
|
|
|
Rajendran L, Simons K. on PAPER: Marchesi VT. et al., 2005, The hypothesis by Vincent Marchesi is attractive and timely. Given that considerable effort in... 8 Nov 2005.
|
|
|
|
|
|
Rajendran L, Simons K. on LIVE DISCUSSION: Messing with the Membrane—An Alternative Interpretation of the Amyloid-β Hypothesis, The hypothesis by Vincent Marchesi is attractive and timely. Given that considerable effort in... 8 Nov 2005.
|
|
|
|
|
|
|
1 to 16 of 16 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
